2024 BrainChip Discussion, page-5956

First 5956 Last

Share
Profile

Follow
manny100

5,625 Posts.

2469

11/06/24

17:30

Post #: 74264299
Share

Originally posted by Fact Finder: ↑

Actually if you attended the previous AGM you would have heard my concerns regarding ASX announcements raised and the answers given. Indeed everyone in attendance and who were on line heard them as well.

This is how we all know the CEO, Chair and Boards interpretation of the Continuous Disclosure Rules.

Unlike some who think asking the same question over and over will lead to a different answer my questions were asked in the presence actual shareholders and they answered.

I also asked took up the issue at the retail shareholder meeting in Sydney last year again in he presence of real shareholders in greater depth with the CEO and Carrick. I reported that on another place and it was posted here.

No secrets at my end I don’t even hide my profile here unlike yourself.

These very important matters you feel necessary to post about were now as you make clear not significant enough in your mind to raise and hold the Board accountable over at the AGM in the presence of shareholders. For some reason you have only ever raised them privately with the CEO and Chair???

At the 2024 AGM the CEO and Chair addressed questions regarding communication and said they had listened and were working to improve same. You say they have not done so yet it is about three weeks and we have had:

1. A full recording of the AGM released.

2. CEO presentation to Pitt Street Research.

3. Research report published on TENNs and polynomials.

4. A press release regarding a new partnership in Europe.

5. A Todd Vierra presentation of the Edge Box running voice and four cameras.

6. A This is Our Mission Podcast hosted by Sean Hehir CEO.

7. A new White Paper published on the company website.

All in the space of three weeks and still you say there has been no improvement. Perhaps had you shared your solutions at the AGM instead of on social media to a tiny percentage of shareholders you might have achieved your aim and we would have had seven communications in three weeks or would it need eight or nine to satisfy your concerns.

Notice I have not included in my list the Twitter and LinkedIn communications during this period from the Company.

My opinion only DYOR

Fact Finder

Expand

Had to have a laugh. Einstein defined insanity as doing the same things over and over expecting a different result.
Sounds like those you are talking about in your earlier post. You pretty well nailed it.
" Unlike some who think asking the same question over and over will lead to a different answer my questions were asked in the presence actual shareholders and they answered."

BRN Price at posting: 22.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

There are more pages in this discussion • 3,971 more messages in this thread...

First 5956 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change 0.020(8.51%)		Mkt cap ! $500.4M

Open	High	Low	Value	Volume
22.5¢	27.5¢	22.0¢	$8.399M	33.52M

Buyers (Bids)

No.	Vol.	Price($)
6	338805	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	10000	1

View Market Depth

No.	Vol.	Price($)
6	338805	0.255
15	429045	0.250
13	731308	0.245
9	88244	0.240
6	93087	0.235

Price($)	Vol.	No.
0.260	10000	1
0.265	231580	5
0.270	636408	10
0.275	501185	11
0.280	1156121	31

Last trade - 16.10pm 02/10/2024 (20 minute delay)

BRN (ASX) Chart

2024 BrainChip Discussion, page-5956

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

2024 BrainChip Discussion, page-5956

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News